中信建投-天士力(600535)Strong Q2 profit performance,essential drug catalog expected to contribute incremental growth-260722

登录忘记密码注册

>> 中信建投-天士力(600535)Strong Q2 profit performance,essential drug catalog expected to contribute incremental growth-260722

上传日期：	2026/7/22	大小：	762KB
格式：	pdf 共8页	来源：	中信建投
评级：	--	作者：	--
下载权限：	此报告为加密报告

相关研报

中信建投-鼎龙股份(300054)Strong earnings growth in 1H26,with accelerated platform-based expansion-260721
中信建投-佛燃能源(002911)Core city gas business operates steadily,while non-power consumption assessment stimulates green methanol demand-260721
中信建投-特步国际(01368.HK)Core brand faced pressure in 2Q26,while Saucony continued to advance premium positioning-260721
中信建投-Electric Equipment：Weekly Insight_ AI drives PCB demand upgrades, accelerating high-end development and localization of dry film photoresist-260721
中信建投-机械设备：Weekly view_Strong construction machinery sales growth continues,while overseas gas turbine earnings may reinforce the global industry upcycle-260721
中信建投-化工：Global leader in high-end polyolefins,shareholder empowerment further upgrades operating quality and dividend expectations-260721
中信建投-有色金属：Strong fundamentals drive relative outperformance in industrial metals-260721
中信建投-剂泰科技-P(07666.HK)Global licensing deal for MTS-128 completed,accelerating value realization of the AI protein platform-260721
中信建投-小菜园(00999.HK)Strategy continues to be optimized,while store expansion and operational development remain steady and solid-260720
中信建投-京东集团-SW(09618.HK)2Q26 performance preview_Profit inflection point to emerge in 2Q,with revenue expected to return to positive growth in 3Q-260720

Copyright © 2005 - 2021 Nxny.com All Rights Reserved 备案号：蜀ICP备15031742号-1